The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease
about
The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycleBlood-Based Proteomic Biomarkers of Alzheimer's Disease PathologyThe Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationThe non-canonical functions of the heme oxygenasesReverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical UseReverse phase protein microarrays advance to use in clinical trialsRealizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.Mild cognitive impairment: prodromal Alzheimer's disease or something else?Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's diseaseRationalising the role of Keratin 9 as a biomarker for Alzheimer's disease.Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study.Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.Carbon monoxide and the CNS: challenges and achievements.Reverse Phase Protein Microarrays.Neuropsychological Effects of Cerebral Amyloid Angiopathy.Role of Gasotransmitters in Oxidative Stresses, Neuroinflammation, and Neuronal Repair.Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
P2860
Q24301823-3B48FD0F-9525-4EDF-933E-BBD346601D92Q26774743-824CD10D-9204-4E6D-96D7-E3B267EDFB37Q26823454-E232983A-9F93-4FCA-833D-D54C801D778AQ28077113-F654F04B-4B1E-4BFC-8018-77E4A458306DQ28083256-D2355256-EAD9-408D-BD63-F23764CAB4B7Q28384553-EEB2BE55-92A4-45EB-A9DA-53019C81E8CCQ33850616-34714F78-53E3-4CDD-9251-892E07A6E80CQ34207983-9B9392D6-2E34-4F21-A404-1C31CBBB6C4EQ34590312-A57A1C97-601A-4B9A-B7CA-93853126098FQ35866579-3B95137C-2195-4158-92D6-CA265FBA4A30Q36681693-6E64F351-226F-4B8D-A428-F810F57B1732Q36740479-4103564A-DE05-48C4-A5AA-A85808A7C170Q38162657-B1B95060-9800-43B1-B78B-9AAC620FEB46Q38206577-B4C56D13-E274-4CB7-8070-DB5DE4BFE84DQ38787411-3CECE427-A28D-424A-88FC-591B6157374BQ38881022-BBC16AF7-41A2-48AC-80BC-65F37E7C2B44Q42136680-5973C2CA-C3BC-497F-A0F2-528997B2F7BCQ42683481-F8E399D9-2DF4-4DAB-8C36-1FD0381C1393
P2860
The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The heme degradation pathway i ...... tection of Alzheimer's disease
@ast
The heme degradation pathway i ...... tection of Alzheimer's disease
@en
type
label
The heme degradation pathway i ...... tection of Alzheimer's disease
@ast
The heme degradation pathway i ...... tection of Alzheimer's disease
@en
prefLabel
The heme degradation pathway i ...... tection of Alzheimer's disease
@ast
The heme degradation pathway i ...... tection of Alzheimer's disease
@en
P2093
P2860
P356
P1476
The heme degradation pathway i ...... tection of Alzheimer's disease
@en
P2093
Amy Vanmeter
Cindy Dickson
Claudius Mueller
Lance A Liotta
Mark M Ross
Matthew Schrag
Michael Heiby
Shino Magaki
Weidong Zhou
Wolff M Kirsch
P2860
P304
P356
10.3233/JAD-2010-1303
P577
2010-01-01T00:00:00Z